118 related articles for article (PubMed ID: 7509088)
1. Hepatitis C virus infection and allogeneic bone marrow transplantation.
Norol F; Roche B; Girardin MF; Kuentz M; Desforges L; Cordonnier C; Duedari N; Vernant JP
Transplantation; 1994 Feb; 57(3):393-7. PubMed ID: 7509088
[TBL] [Abstract][Full Text] [Related]
2. The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group.
Locasciulli A; Testa M; Valsecchi MG; Bacigalupo A; Solinas S; Tomas JF; Ljungman P; Alberti A
Transplantation; 1999 Nov; 68(10):1486-91. PubMed ID: 10589944
[TBL] [Abstract][Full Text] [Related]
3. [Reduction of the post-transfusion hepatitis C risk in patients undergoing bone marrow allograft].
Norol F; Roche B; Saint Marc Girardin MF; Kuentz M; Desforges L; Cordonnier C; Duedari N; Vernant JP
Rev Fr Transfus Hemobiol; 1993 Dec; 36(6):499-507. PubMed ID: 7509605
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation.
Erer B; Angelucci E; Lucarelli G; Giardini C; Baronciani D; Galimberti M; Polchi P; Amadei G; Battistini L; Paolucci S
Bone Marrow Transplant; 1994 Sep; 14(3):369-72. PubMed ID: 7527690
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection and liver disease after allogeneic bone marrow transplantation.
Fujii Y; Kaku K; Tanaka M; Kaneko T; Matumoto N; Shinohara K
Bone Marrow Transplant; 1994 May; 13(5):523-6. PubMed ID: 7519934
[TBL] [Abstract][Full Text] [Related]
6. Anti-HCV seroconversion in multitransfused and immunocompromised patients. A long-term longitudinal study.
Cornu C; Brusselmans C; Geubel A; Ferrant A; Cornu G
Vox Sang; 1994; 67(3):286-90. PubMed ID: 7532342
[TBL] [Abstract][Full Text] [Related]
7. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation.
Locasciulli A; Bacigalupo A; Vanlint MT; Tagger A; Uderzo C; Portmann B; Shulman HM; Alberti A
Transplantation; 1991 Aug; 52(2):315-8. PubMed ID: 1714641
[TBL] [Abstract][Full Text] [Related]
9. Role of screening for hepatitis C virus in children with malignant disease and who undergo bone marrow transplantation.
Tada K; Tajiri H; Kozaiwa K; Sawada A; Guo W; Okada S
Transfusion; 1997 Jun; 37(6):641-4. PubMed ID: 9191826
[TBL] [Abstract][Full Text] [Related]
10. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
[TBL] [Abstract][Full Text] [Related]
11. Incidence of post-transfusion hepatitis before and after screening for hepatitis C virus antibody.
Wang YJ; Lee SD; Hwang SJ; Chan CY; Chow MP; Lai ST; Lo KJ
Vox Sang; 1994; 67(2):187-90. PubMed ID: 7528456
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C infection in BMT patients.
Kolho E; Ruutu P; Ruutu T
Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597
[TBL] [Abstract][Full Text] [Related]
13. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
Shuhart MC; Myerson D; Spurgeon CL; Bevan CA; Sayers MH; McDonald GB
Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
[TBL] [Abstract][Full Text] [Related]
15. Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission.
Jullien AM; Couroucé AM; Massari V; Maniez M; Finetti P; Brevière D; Girard M; Andréani T; Habibi B
Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):668-72. PubMed ID: 8243482
[TBL] [Abstract][Full Text] [Related]
16. The declining risk of post-transfusion hepatitis C virus infection.
Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
[TBL] [Abstract][Full Text] [Related]
17. Incidence of hepatitis and seroconversion to hepatitis C virus after open-heart surgery in transfused and non-transfused patients in Sweden.
Mattsson L; Aberg B; von Sydow M; Weiland O
Scand J Infect Dis; 1991; 23(1):25-9. PubMed ID: 1851323
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to hepatitis C virus in transfused children with cancer.
Monteleone PM; Andrzejewski C; Kelleher JF
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients.
Rostaing L; Izopet J; Cisterne JM; Icart J; Chabannier MH; Panicali H; Durand D
Am J Nephrol; 1997; 17(1):46-52. PubMed ID: 9057953
[TBL] [Abstract][Full Text] [Related]
20. Frequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second- and third-generation assays.
Makris K; Kouvelis V; Drakopoulos I; Oikonomou E; Maniatis A
Transfus Med; 1995 Sep; 5(3):213-24. PubMed ID: 8593527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
